Fulcrum Therapeutics, Slate Medicines announce merger agreement
Fulcrum Therapeutics and Slate Medicines announce a merger agreement to advance next-generation migraine therapies.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.